000 02485 a2200721 4500
005 20250516214503.0
264 0 _c20150707
008 201507s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-14-0012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAmiri-Kordestani, Laleh
245 0 0 _aFDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cSep 2014
300 _a4436-41 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650 0 4 _aAdo-Trastuzumab Emtansine
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aDrug Approval
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMaytansine
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aReceptor, ErbB-2
_xgenetics
650 0 4 _aTrastuzumab
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aBlumenthal, Gideon M
700 1 _aXu, Qiang Casey
700 1 _aZhang, Lijun
700 1 _aTang, Shenghui W
700 1 _aHa, Linan
700 1 _aWeinberg, Wendy C
700 1 _aChi, Bo
700 1 _aCandau-Chacon, Reyes
700 1 _aHughes, Patricia
700 1 _aRussell, Anne M
700 1 _aMiksinski, Sarah Pope
700 1 _aChen, Xiao Hong
700 1 _aMcGuinn, W David
700 1 _aPalmby, Todd
700 1 _aSchrieber, Sarah J
700 1 _aLiu, Qi
700 1 _aWang, Jian
700 1 _aSong, Pengfei
700 1 _aMehrotra, Nitin
700 1 _aSkarupa, Lisa
700 1 _aClouse, Kathleen
700 1 _aAl-Hakim, Ali
700 1 _aSridhara, Rajeshwari
700 1 _aIbrahim, Amna
700 1 _aJustice, Robert
700 1 _aPazdur, Richard
700 1 _aCortazar, Patricia
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 20
_gno. 17
_gp. 4436-41
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-14-0012
_zAvailable from publisher's website
999 _c23872241
_d23872241